Loading...
Hang Chi Holdings Limited
8405.HK•HKSE
Healthcare
Medical - Care Facilities
HK$0.69
HK$0.010(1.47%)

Over the last four quarters, Hang Chi Holdings Limited's revenue moved from $54.61M in Q3 2023 to $59.13M in Q2 2024. Operating income in Q2 2024 was $9.56M, with a strong operating margin of 16%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Hang Chi Holdings Limited remained robust at $10.75M, reflecting operational efficiency. Net income rose to $6.23M, with an EPS of $0.03. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan